【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 18
1.2 List of Figures 25
2 Introduction 29
2.1 Catalyst 30
2.2 Related Reports 31
3 Disease Overview 32
3.1 Overview 32
3.1.1 Coronary Artery Disease 32
3.1.2 Peripheral Artery Disease 32
3.2 Anatomy and Physiology 33
3.2.1 Coronary Arteries 33
3.2.2 Peripheral Arteries of the Lower Extremity 34
3.3 Pathophysiology 36
3.3.1 Coronary Artery Disease 36
3.3.2 Peripheral Artery Disease 37
3.4 Clinical Presentation 38
3.4.1 Symptoms 38
3.4.2 Risk Factors 41
3.4.3 Disease Classification 42
3.4.4 Diagnosis 43
3.4.5 Clinical Outcomes 46
3.5 Epidemiology 79
3.5.1 Coronary Artery Disease 79
3.5.2 Peripheral Artery Disease 84
3.6 Economic Impact of Coronary and Peripheral Artery Disease 90
3.6.1 Cost of Coronary Artery Disease 90
3.6.2 Cost of Peripheral Artery Disease 94
3.6.3 Treatment Costs of Coronary and Peripheral Artery Disease 96
4 Competitive Assessment 99
4.1 Overview 99
4.2 Product Profiles by Company 101
4.2.1 Aachen Resonance 102
4.2.2 B. Braun 104
4.2.3 Biotronik 111
4.2.4 Blue Medical 114
4.2.5 Cardionovum 120
4.2.6 C.R. Bard 126
4.2.7 Concept Medical Research 132
4.2.8 Cook Medical 136
4.2.9 Eurocor 138
4.2.10 Medrad (Bayer Healthcare) 153
4.2.11 Medtronic 155
4.2.12 Minvasys 163
5 Unmet Needs 166
5.1 Need for Better Clinical Outcomes in Specific Lesions 166
5.1.1 Chronic Total Occlusions 166
5.1.2 Small-Vessel Coronary Lesions 167
5.1.3 Long Lesions 167
5.1.4 Heavily-Calcified and Uncrossable/Undilatable Lesions 168
5.1.5 Bifurcation Lesions 168
5.2 Need for Better Revascularization of the Femoropopliteal Artery 169
5.3 Difficulty in Treating the Infrapopliteal Artery 171
5.4 Eliminating Mechanisms of Failure with Balloon Angioplasty 172
5.5 Addressing Challenges of Stenting 174
5.5.1 Risk of Post-Procedural Complications 174
5.5.2 In-Stent Restenosis 176
5.5.3 Stent-In-Stent Procedures 177
5.5.4 Prolonged Dual Antiplatelet Therapy 178
5.5.5 Lack of Homogenous Drug Distribution 179
5.5.6 Delayed Healing 179
5.5.7 Stent Fracture 180
5.5.8 Negative Vessel Remodeling 181
5.5.9 Long-Term Vessel Patency 182
5.6 Need for Effective Therapy for Specific Patient Populations 182
5.7 Lack of Clinical Data 183
5.8 Addressing the Complications of Bypass Surgery 183
5.9 Need to Improve Medical Therapy 184
5.10 Comparative Studies on Exercise Therapy for PAD 185
6 Pipeline Products 186
6.1 Overview 186
6.2 Pipeline by Stage of Development 187
6.3 Pipeline Product Profiles 189
6.3.1 NF-κB Decoy Oligo DEB 189
6.3.2 Drug-Coated AngioSculpt 191
6.3.3 BioPath 194
6.3.4 BioStream 195
6.3.5 Boston Scientific Drug-Coated Balloon 196
6.3.6 Coroflex DEBlue 197
6.3.7 Covidien Drug-Coated Balloon 199
6.3.8 Caliber Therapeutics DEB 201
6.3.9 Elixir Medical Corporation DCB 202
6.3.10 LifeTech Scientific Corporation DEB 202
6.3.11 Micell Technologies Drug-Coated Balloon 202
6.3.12 Drug-Coated Chocolate DEB 204
6.3.13 Passeo-18 Lux 206
6.3.14 Vascular Nanotransfer Technologies Drug-Coated Balloon 207
6.3.15 WOMBAT DCB 208
7 Clinical Trial Analysis 210
7.1 Overview 210
7.2 Clinical Trials to Watch 210
7.2.1 Drug-Eluting Balloons 210
7.2.2 Vascular Stents 224
8 Industry Overview 229
8.1 Procedure Trends 229
8.1.1 Factors Contributing to the Rise of Coronary and Peripheral Interventions 229
8.1.2 Coronary Artery Disease 230
8.1.3 Peripheral Artery Disease 235
8.2 Physician Decision-Making Process 243
8.3 Market Access 245
8.3.1 United States 246
8.3.2 European Union 253
8.3.3 Asia-Pacific Region 262
8.3.4 South America 271
8.4 Regulatory Issues/Recalls 275
8.4.1 Regulatory Issues 275
8.4.2 Product Recalls 276
8.5 Mergers and Acquisitions/Partnerships 276
8.5.1 Biosensors International and Eurocor 276
8.5.2 Boston Scientific Corporation and Guidant Corporation 277
8.5.3 Covidien and ev3, CV Ingenuity 277
8.5.4 C.R. Bard and Lutonix 278
8.5.5 Micell Technologies and Maxcor Lifescience 278
8.5.6 Medrad and Bayer 279
8.5.7 Medtronic and Invatec 279
9 Current and Future Players 280
9.1 Overview 280
9.2 Trends in Corporate Strategy 281
9.3 Company Profiles 284
9.3.1 Aachen Resonance 284
9.3.2 AnGes MG 285
9.3.3 AngioScore 287
9.3.4 AVIDAL Vascular 289
9.3.5 B. Braun 291
9.3.6 Biosensors International 293
9.3.7 Biotronik 295
9.3.8 Blue Medical 297
9.3.9 Boston Scientific Corporation 299
9.3.10 Caliber Therapeutics 301
9.3.11 Cardionovum 303
9.3.12 Concept Medical Research 305
9.3.13 Cook Medical 307
9.3.14 Covidien 308
9.3.15 C.R. Bard 310
9.3.16 Elixir Medical Corporation 312
9.3.17 Eurocor 314
9.3.18 LifeTech Scientific Corporation 316
9.3.19 Medtronic 318
9.3.20 Micell Technologies 320
9.3.21 Minvasys 321
9.3.22 TriReme Medical 323
9.3.23 Vascular Nanotransfer Technologies 325
10 Market Drivers, Opportunities, Barriers and Substitutes 327
10.1 Market Drivers 327
10.1.1 Rising Prevalence of Disease 328
10.1.2 Viable Treatment for Select Indications 329
10.1.3 No Metal Left Behind 334
10.1.4 Avoid Stent-in-Stent Procedures 335
10.1.5 Reduce the Need for Prolonged Dual Antiplatelet Therapy 336
10.1.6 Enhanced Vessel Healing and Better Patency 336
10.1.7 Technical Feasibility of Future Interventions 337
10.1.8 DEB as an Adjunctive Therapy 338
10.1.9 Limb Amputation 338
10.1.10 Cost Savings 339
10.1.11 Availability of Long-Term and Cost-Effective Data 340
10.1.12 Launch of DEB in the US 340
10.2 Opportunities 341
10.2.1 Improve DEB Design 341
10.2.2 DEB Hybrid Systems (DEB + Stent) 345
10.2.3 Target Indications Where Stenting is Not Satisfactory 345
10.2.4 Challenges in Treating the Femoropopliteal and Infrapopliteal Arteries 348
10.2.5 Target Challenging Patient Populations 350
10.2.6 Launch DEB in the Japanese Market 351
10.2.7 Emerging Markets 351
10.3 Market Barriers 352
10.3.1 Slow Adoption 352
10.3.2 High Selling Prices 356
10.3.3 Lack of Reimbursement 357
10.3.4 US FDA Regulatory Challenges 358
10.3.5 Healthcare Cost-Cutting and Reimbursement 359
10.3.6 Availability of Venture Capital 360
10.3.7 Medical Device Excise Tax 361
10.4 Market Substitutes 361
10.4.1 Vascular Stents 361
10.4.2 Liquid Drug Delivery Catheter 365
11 Drug-Eluting Balloon Market Analysis 368
11.1 Global Market Overview 368
11.2 Market Analysis by Type of Disease 369
11.2.1 Coronary Artery Disease 369
11.2.2 Peripheral Artery Disease in the Lower Extremity 370
11.3 Market Distribution by Indication 373
11.4 Primary Versus Adjunctive Therapy 375
11.5 Comparative Market Analysis 377
11.5.1 Coronary Artery Disease 377
11.5.2 Peripheral Artery Disease in the Lower Extremity 379
12 Country Outlooks & Forecasts 381
12.1 Overview 381
12.2 United States 383
12.2.1 Overview 383
12.2.2 Market Analysis 383
12.3 France 386
12.3.1 Overview 386
12.3.2 Market Analysis 386
12.4 Germany 389
12.4.1 Overview 389
12.4.2 Market Analysis 389
12.5 Italy 393
12.5.1 Overview 393
12.5.2 Market Analysis 393
12.6 Spain 396
12.6.1 Overview 396
12.6.2 Market Analysis 396
12.7 United Kingdom 398
12.7.1 Overview 398
12.7.2 Market Analysis 398
12.8 Japan 401
12.8.1 Overview 401
12.8.2 Market Analysis 401
12.9 Brazil 404
12.9.1 Overview 404
12.9.2 Market Analysis 404
12.10 China 406
12.10.1 Overview 406
12.10.2 Market Analysis 406
12.11 India 409
12.11.1 Overview 409
12.11.2 Market Analysis 409
13 Appendix 413
13.1 Bibliography 413
13.2 Abbreviations 445
13.3 Report Methodology 449
13.3.1 Overview 449
13.3.2 Coverage 449
13.3.3 Secondary Research 449
13.3.4 Forecasting Methodology 450
13.4 Physicians and Specialists Included in this Study 452
13.5 Physician Survey 455
13.6 About the Authors 456
13.6.1 Analysts 456
13.6.2 Global Head of Healthcare 457
13.7 About MediPoint 458
13.8 About GlobalData 458
13.9 Disclaimer 458
【レポート販売概要】
■ タイトル:薬剤溶出バルーン(DEB):グローバル市場分析と予測■ 英文:MediPoint: Drug-Eluting Balloons - Global Analysis and Market Forecasts
■ 発行日:2013年9月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162211
■ 調査対象地域:グローバル
- LTEネットワーク上の無線セキュリティ市場2013-2018(Wireless Security Market in LTE Networks 2013-2018)With the rapid expansion of broadband wireless, end-users increasingly rely upon handheld devices for almost all daily living activities. Fourth generation (4G) cellular LTE in particular represents a unique opportunity/challenge as device attacks are growing at a rapid rate, exposing vulnerabilities that must be addressed. Our research indicates that Android malware in particular will grow rapidl …
- モノクロル酢酸の世界市場2015-2019About MCAA MCAA, also called chloroacetic acid, is a bi-functional molecule-structured acid. It is extensively used as a chemical intermediate for the production of numerous industrially and commercially important chemicals, including glycine, CMC, TGA, and cyanoacetic acid. It is also used in the production of betaine-type surfactants, synthetic caffeine, and vitamins, and the production of 2,4-D …
- 心臓バイオマーカーの世界市場分析:タイプ別(トロンポニン、クレアチンキナーゼ-MB(CK-MB)、ナトリウム利尿ペプチド-B型ナトリウム利尿ペプチド(BNP)・N末端プロb型ナトリウム利尿ペプチド(NT-proBNP)、ミオグロビン、虚血修飾アルブミン(IMA)、心臓型脂肪酸結合タンパク質(H-FABP)、LDHアイソザイム)、用途別(急性冠動脈症候群、心筋梗塞、うっ血性心不全、心筋症、虚血、心筋炎、心房細動)、エンドユーザー別、地域別、セグメント予測The cardiac biomarkers market is expected to reach USD13.3 billion by 2024, according to a new report by Grand View Research, Inc. The cardiac biomarkers market is anticipated to witness a lucrative growth during the forecast period from 2016 to 2024. Analysis of global market trends focuses on the increasing demand for cardiac biomarkers owing to its increased adoption in cardiovascular disease d …
- 不妊治療サービスの世界市場:手順別(ICSIを伴うIVF、IUI、ICSIを伴わないIVF、代理出産、その他)、サービス別(新鮮な非ドナー、冷凍の非ドナー、卵および胚銀行、新鮮なドナー、および冷凍のドナー)The global fertility services market generated $13,655 million in 2018 and is projected to reach $27,151 million by 2026, growing at a CAGR of 8.9% from 2019 to 2026 Fertility services are services availed by people who are unable to conceive naturally. These services help infertile couples, single parents, and LGBT community to procreate and start a family. In vitro fertilization and other assist …
- 形鋼の世界市場2016-2020About Steel Sections Steel sections are a type of steel long products and are used for different applications in industries, including infrastructure and construction, power, industrial machinery, and railway. These provide stability and strength to the structure. Other steel long products include rebars, wire rods, tubes, hot rolled bars, and rails. The global steel long products market will grow …
- 美容医療の世界市場:デンタルインプラント、顔美容、レーザ美容医療、乳房インプラントTechnavios market research analyst predicts the global medical aesthetics market to grow steadily at a CAGR of approximately 7% by 2020. Factors such as the growing aging population, increased awareness about cosmetic surgeries, and the rise in high-income population are expected to foster the prospects for growth in this market during the estimated period. Recent advances in technologies, especia …
- Gastrointestinal Bleeding:グローバル臨床試験レビューH2, 2013Gastrointestinal Bleeding Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Gastrointestinal Bleeding Global Clinical Trials Review, H2, 2013" provides data on the Gastrointestinal Bleeding clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastrointestinal Bleeding. It includes an overview of the trial …
- 工業オートメーションにおける仮想化技術の世界市場2018-2022About Virtualization in Industrial Automation Virtualization is a technology that makes use of software to create multiple simulated environments from a single hardware system. Hypervisor is a software that disengages virtual machines (VMs)from host servers and assigns computer resources to the VMs. Technavio’s analysts forecast the global virtualization in industrial automation market to grow at …
- 高性能フィルムの世界市場2015-2022According to Stratistics MRC, the High Performance Films Market accounted for $28.34 billion in 2015 and is expected to reach $49.56 billion by 2022 growing at a CAGR of 8.3% from 2015 to 2022. Rising technological advancements in field of high performance films is one of the key factors fueling the market growth. However, factors such as huge capital cost and high level of technical competency ar …
- 医療用チューブの世界市場予測(~2021年):PVC、ポリオレフィン、TPE、TPU、シリコンチューブThe medical tubing market size is projected to witness a CAGR of 8.0% from 2016 to reach a market size of USD 5.85 Billion, by 2021. The market is mainly driven by minimally invasive surgery. Another major factor that is expected to bring momentum to this market are increasing aging population, especially in developing countries, and the rising awareness about healthcare and the government initiat …
- 虹彩認証の世界市場2016-2020About Iris Recognition Iris recognition is one of the most secure, and accurate biometrics modality that is used for security and surveillance purposes in sectors such as government, military and defense, healthcare, banking and finance, consumer electronics, travel and immigration, and automotive. This biometrics technology came into existence in 1994 and many countries across the globe have depl …
- IoTマネジードサービスの世界市場予測(~2021年)Growing inclination toward cost-efficient managed services is expected to drive the growth of the IoT managed services marketThe IoT managed services market size is expected to grow from USD 21.85 billion in 2016 to USD 79.60 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 29.5% during the period 2016–2021. The major drivers for the upsurge in demand for the IoT managed services market …
- 世界の3D薄型テレビ市場動向(2014~2018)TechNavio's analysts forecast the Global 3D Flat Panel TV market to grow at a CAGR of 15.4 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in 3D content broadcasts. The Global 3D Flat Panel TV market has also been witnessing the emergence of 4K resolution technology. However, the health risk associated with 3D technology could pose a cha …
- Lundin Petroleum AB:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Lundin Petroleum AB Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Lundin Petroleum AB Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 薄ウェハの世界市場動向・予測(~2020)The thin wafer market was valued at 6.76 Billion in 2015, and is estimated to reach USD 9.17 Billion by 2022 with a CAGR of 3.7% between 2016 and 2022. The increasing demand for semiconductor devices in several industries such as automotive, consumer electronics, and telecommunication among many others impacts the market positively. Thin wafers have applications LEDs, MEMS, CIS, power devices, RF …